The tripeptide modulates over 4,000 human genes (31.2% of the genome) and plasma levels decline from approximately 200 ng/mL at age 20 to less than half by age 60 (Pickart & Margolina, 2018)
For eloralintide, GI symptoms and fatigue were the most common adverse events, mild to moderate, and clearly dose-dependent: they appeared more often in the higher-dose arms, occurred less often with slower escalation, and ran at rates similar to placebo in the 1 mg and 3 mg arms
If you are curious whether this growth hormone support strategy fits your goals, the next step is a conversation with a clinician who can walk you through your options and help you build a plan that makes sense for you
Both options include your medical evaluation, the compounded KLOW blend, injection supplies, and ongoing provider access for questions during your cycle